This website and our authorized third-party service providers use cookies to achieve the purposes described in our Privacy Policy. If you would like to learn more or withdraw your consent to some or all cookies, please review our Privacy Policy. By selecting “I ACCEPT” on this banner, scrolling this page, clicking any link, or continuing to browse this site, you agree to the use of cookies.
Three employees of Warner Chilcott, a pharmaceutical company headquartered in New Jersey, were sentenced to home confinement and levied fines, each to varying degrees, for violations of the Health Insurance Portability and Accountability Act (HIPAA) and its privacy provisions.
The three district managers -- one located in California, one in North Carolina and one in New York -- were prosecuted by the Department of Justice (DOJ) for selling consumers' protected health information (PHI) without the subjects' permission.
These district managers and their sales representatives accessed patients' PHI in order to submit prior authorizations for Atelvia, an osteoporosis drug, and did so without an accompanying signed HIPAA Authorization Form for each consumer.